Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Pharmacology

• Publication date

  1991-02-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0014-2999(91)90040-WPMID 2050198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proconflict and electrocorticographic effects of drugs modulating GABAergic neurotransmission

  2004cited by this paper
• Long-term potentiation in the rat hippocampus induced by the mast cell degranulating peptide: analysis of the release of endogenous excitatory amino acids and proteins.

  1990cited by this paper
• K+ channels openers prevent epilepsy induced by the bee venom peptide MCD.

  1989cited by this paper
• Ibotenic acid stimulates D-[3H]aspartate release from cultured cerebellar granule cells.

  1989cited by this paper
• Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils

  1989cited by this paper
• Subtypes of K+ channels differentiated by the effect of K+ channel openers upon K+ channel blocker-induced seizures.

  1989cited by this paper
• Ca2+ channel blockers prevent seizures induced by a class of K+ channel inhibitors.

  1989cited by this paper
• Analogies and differences in the mode of action and properties of binding sites (localization and mutual interactions) of two K+ channel toxins, MCD peptide and dendrotoxin I.

  1989cited by this paper
• Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.

  1988cited by this paper
• The receptor site for the bee venom mast cell degranulating peptide. Affinity labeling and evidence for a common molecular target for mast cell degranulating peptide and dendrotoxin I, a snake toxin active on K+ channels.

  1988cited by this paper
• Excitatory effects of cholecystokinin in rat hippocampus: pharmacological response compatible with 'central'- or B-type CCK receptors.

  1988cited by this paper
• Mast cell degranulating peptide and dendrotoxin selectively inhibit a fast-activating potassium current and bind to common neuronal proteins.

  1987cited by this paper
• The brain response to the bee venom peptide MCD. Activation and desensitization of a hippocampal target.

  1987cited by this paper
• Toxin I from the snake Dendroaspis polylepis polylepis: a highly specific blocker of one type of potassium channel in myelinated nerve fiber.

  1986cited by this paper
• Pharmacologically distinct glutamate receptors on cerebellar granule cells.

  1986cited by this paper
• 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.

  1985cited by this paper
• 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.

  1985cited by this paper
• The characterization of high-affinity binding sites in rat brain for the mast cell-degranulating peptide from bee venom using the purified monoiodinated peptide.

  1984cited by this paper
• Two generators of hippocampal theta activity in rabbits.

  1975cited by this paper
• [The significance of the rabbit's septum as a relay station between the midbrain and the hippocampus. I. The control of hippocampus arousal activity by the septum cells].

  1962cited by this paper
• Connections of the cerebral cortex. I. The albino rat. A. Topography of the cortical areas

  1946cited by this paper

• Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in KCNA1-Associated Episodic Ataxia and a Comprehensive Review of the Literature

  2021cites this paper
• Neurological Implications of Dendrotoxin : A Review

  2018cites this paper
• Pharmacological investigation of memory restorative effect of riluzole in mice

  2012cites this paper
• A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in Amyotrophic Lateral Sclerosis

  2012cites this paper
• Anti-glutamatergic effect of riluzole: comparison with valproic acid.

  2007cites this paper
• Interaction of Riluzole with the Closed Inactivated State of Kv4.3 Channels

  2006cites this paper
• Interactions between riluzole and conventional antiepileptic drugs – a comparison of results obtained in the subthreshold method and isobolographic analysis

  2004cites this paper
• Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice.

  2004cites this paper
• Mechanisms of the anti-ischemic effect of vagus nerve stimulation in the gerbil hippocampus

  2003cites this paper
• Mechanisms of the anti-ischemic effect of vagus nerve stimulation in the gerbil hippocampus.

  2003cites this paper
• Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole.

  2002cites this paper
• Twenty years of dendrotoxins.

  2001cites this paper
• Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels.

  2000cites this paper
• The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK.

  2000cites this paper
• The Neuroprotective Agent Riluzole Activates the Two P Domain K+ Channels TREK-1 and TRAAK

  2000cites this paper
• Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat

  1998cites this paper
• A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids

  1998cites this paper
• The KCNQ2 potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with KCNQ3

  1998cites this paper
• Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.

  1998cites this paper
• [Riluzole as a treatment for amyotrophic lateral sclerosis].

  1998cites this paper
• Recent studies on dendrotoxins and potassium ion channels.

  1997cites this paper
• Neuroprotective Profile of Riluzole in In Vivo Models of Acute Neurodegenerative Diseases

  1997cites this paper
• Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study

  1997cites this paper
• G-proteins are involved in riluzole inhibition of high voltage-activated calcium channels in rat dorsal root ganglion neurons.

  1997cites this paper
• Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons.

  1997cites this paper
• Toxins affecting K+ channels.

  1996cites this paper
• Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.

  1996cites this paper
• Riluzole, a Novel Neuroprotective Agent, Attenuates Both Neurologic Motor and Cognitive Dysfunction Following Experimental Brain Injury in the Rat

  1996cites this paper
• A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in Amyotrophic Lateral Sclerosis

  1996cites this paper
• Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.

  1996cites this paper
• Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat.

  1996cites this paper
• Inhibition by riluzole of glycinergic postsynaptic currents in rat hypoglossal motoneurones

  1995cites this paper
• Glutamate-induced overexpression of NMDA receptor messenger RNAs and protein triggered by activation of AMPA/kainate receptors in rat hippocampus following forebrain ischemia.

  1994cites this paper
• Effect of riluzole on focal cerebral ischemia in rats.

  1993cites this paper
• Neuropharmacology of potassium ion channels

  1993cites this paper
• Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.

  1992cites this paper
• Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia.

  1992cites this paper